Provided by Tiger Fintech (Singapore) Pte. Ltd.

LIVZON PHARMA

27.950
+0.5502.01%
Volume:2.20M
Turnover:61.46M
Market Cap:25.27B
PE:11.43
High:28.300
Open:27.950
Low:27.250
Close:27.400
Loading ...

Company Profile

Company Name:
LIVZON PHARMA
Exchange:
SEHK
Establishment Date:
1985
Employees:
9067
Office Location:
Headquarters Building,No. 38 Chuangye North Road,Jinwan District,Zhuhai,Guangdong Province,China
Zip Code:
519090
Fax:
86 75 6888 6002
Introduction:
Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The Company's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The Company's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The Company mainly operates its businesses in the domestic and overseas markets.